Ewing sarcoma is a medical term used for a rare/uncommon and aggressive type of bone cancer, affecting mostly children, teenagers/adolescents, and young adults, that originates in primitive nerve tissue cells and primarily affects bones, but can also start in the soft tissues surrounding bones. The disease requires immediate diagnosis and multimodal treatment, given its rapid progression and potential to spread to specific parts of the body.
The condition usually occurs in the long bones of the body, such as the thigh, shin, and upper arm, as well as in the pelvis, rib cage, and vertebral column. It can also arise in the soft tissues of the chest wall, abdomen, and limbs as extraosseous Ewing's sarcoma.
Ewing sarcoma is a part of a group of tumors collectively referred to as the Ewing sarcoma family of tumors (ESFT). Over the last few decades, improvements in chemotherapy, surgical methods, and radiation therapy have led to better treatment results.
Ewing sarcoma harbors two distinct genetic mutations, as evidenced by a translocation involving chromosomes 11 and 22. This genetic mutation causes the aberrant fusion gene EWSR1-FLI1 that results in cellular proliferation.
Ewing sarcoma shows no link with environmental factors, lifestyle choices, or heredity risks, which affect most adult cancers.
The tumor's location and size determine how symptoms present themselves. The first signs of the disease may be mistaken for sports injuries or growing pains because it affects the bones of youngsters who are still developing.
The condition presents through these main indications and primary symptoms:
The mild symptoms at the onset of the disease delay diagnosis for patients.
The patient requires medical assessment for persistent bone pain that lasts longer than three weeks. The doctor needs to assess patients with bone pain lasting more than 3 weeks.
Ewing sarcoma develops without known causes. Random genetic mutations that occur in developing cells result in this condition. The chromosomal translocation that defines the disease arises randomly from genetic mutations and does not follow a pattern of inheritance.
Researchers have not found any effective preventive methods because there are no risk factors that people can change.
The disease requires early diagnosis because Ewing sarcoma shows aggressive growth, yet treatment can lead to successful outcomes when started early.
The doctors assess the patient's health by examining swelling and tenderness, range of motion, and the patient's overall condition. The medical staff collects a complete medical history, including all symptoms the patient has experienced since they first appeared.
Imaging tests are crucial for both diagnosing Ewing sarcoma and tracking the disease's course.
Diagnosis confirmation requires a biopsy. The medical staff removes a tiny piece of tumor tissue, which they analyze under a microscope. The testing process identifies the genetic translocation that defines Ewing sarcoma.
The medical professional who performs the biopsy must be an experienced orthopedic oncologist or surgical oncologist to guarantee accurate surgical plans for the patient.
Ewing sarcoma requires bone marrow evaluation through marrow samples because its cancerous cells spread into the bone marrow.
Ewing sarcoma has three main stages, which the medical professionals use to categorize the disease:
The stage of the disease directly impacts both the treatment plan and the patient's expected outcome.
Ewing sarcoma treatment uses multiple methods that combine chemotherapy with surgical procedures and radiation treatment. The medical team needs to work with specialized doctors, including pediatric oncologists, medical oncologists, orthopedic oncologists, radiation oncologists, radiologists, and rehabilitation specialists.
The main treatment method for the disease involves chemotherapy, which starts immediately after the diagnosis. The treatment process begins with neoadjuvant chemotherapy, which decreases the tumor size and targets hidden cancerous cells.
The medical community uses these chemotherapy medications in combination with each other:
Chemotherapy treatment continues after surgical procedures to remove any remaining cancer cells from the body.
Ewing sarcoma patients experience better survival outcomes through chemotherapy treatment because the disease responds well to this method.
Doctors perform tumor removal surgery after the patient has undergone their first chemotherapy session. The medical team aims for complete tumor removal, which should result in clean margins while they try to keep the patient's limb function intact.
Doctors have developed techniques that enable limb-sparing surgery, enabling patients to retain their limbs. Doctors use bone grafts and artificial devices to reconstruct the anatomical structures.
Surgical procedures become more intricate when the tumor exists in the pelvic area or spinal column because they require specific surgical skills.
Radiation therapy may be used:
Modern radiation techniques aim to minimize long-term side effects, which particularly affect children who are still growing.
Patients with metastatic Ewing sarcoma need to undergo intensive chemotherapy treatment and may require radiation therapy for their metastatic tumors. Doctors may use whole-lung radiation to treat selected cases of lung metastases.
Some high-risk patients might need high-dose chemotherapy with stem cell rescue as their treatment option.
Patients experience two main types of complications: those caused by the disease and those caused by medical treatment.
Proper monitoring, combined with supportive health services, reduces the risks associated with medical treatment.
Recovery from cancer treatment extends into a period that goes beyond the patient's cancer treatment. The majority of patients require the following medical services:
Patients require regular imaging tests, which help to identify cancer recurrence during the long-term follow-up period. The majority of cancer recurrences happen during the initial years after patients complete their treatment.
The patient's prognosis depends on three critical factors, which include the following:
Patients with localized Ewing sarcoma have significantly higher survival rates compared to those who have metastatic disease. The introduction of multidisciplinary care, together with advanced chemotherapy, has enhanced long-term survival rates for patients during the past several decades.
The medical community considers metastatic disease at the time of diagnosis to be a difficult challenge that needs strong treatment.
Follow-up visits allow the doctor to check for any possible return of cancer and also take care of any side effects that may be the result of previously conducted treatment.
Tender Palm Super-Speciality Hospital offers advanced Ewing Sarcoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced orthopedic oncologists and surgical specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including chemotherapy, surgical resection, and radiation therapy. Our Orthopedic Oncology and Surgical Care team has decades of experience in successfully treating Ewing Sarcoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com